FIELD: medicine.
SUBSTANCE: invention refers to medicine and represents a method for prediction of clinical course of chronic cardiac insufficiency in patients with ischemic heart disease, characterised by, that in blood serum protein apoptosis-mediated factor-soluble Fas ligand- is defined and if the level of soluble Fas ligand more 99.9 pg/mL, the unfavourable course of disease is prognosticated.
EFFECT: invention implementation allows to increase accuracy of prognostication of cardiac failure.
1 cl, 4 tbl, 2 dwg, 2 ex
